Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KPG-818 by Kangpu Biopharmaceuticals for Systemic Lupus Erythematosus: Likelihood of Approval
KPG-818 is under clinical development by Kangpu Biopharmaceuticals and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData,...